Rs11655505
From SNPedia
| is a | snp |
| is | mentioned by |
| dbSNP | rs11655505 |
| hapmap | rs11655505 |
| hgdp | rs11655505 |
| ensembl | rs11655505 |
| gopubmed | rs11655505 |
| scholar | rs11655505 |
| rs11655505 | |
| pharmgkb | rs11655505 |
| hgvbaseg2p | rs11655505 |
| medrefsnp | rs11655505 |
| 23andMe | rs11655505 |
| SNP Nexus |
| Chromosome | 17 |
| Orientation | plus |
| Position | 38531902 |
| Genotype | Effect |
|---|---|
| rs11655505(A;A)* | ? |
| rs11655505(A;G)* | ? |
| rs11655505(G;G)* | ? |
| PharmGKB | PA162370344 |
| Name | BRCA1: -2265C>T |
| Annotation | This variant is in the promoter region of BRCA1. T allele is associated with increased promoter activity compared with the A allele. The carriers of T allele had a reduced risk of breast cancer in chinese women. The associate is more prominent in women aged >=45 years, particularly those without a family history of breast cancer. |
| Gene | NBR2, BRCA1 |
| Featue | |
| Evidence | PubMed ID:18782836 |
| Drugs | |
| Diseases | Breast Neoplasms, Neoplasms |
| Curation Level | Curated |
